SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan Schonsheck who wrote (3550)4/8/1998 2:56:00 PM
From: Hank  Read Replies (1) of 4342
 
Jonathan,

I think that we would only need a handful of these 173 extracts to fly in order to see a real turn around in the making. If in addition to the launch of dietary supplements we also saw at least one extract lead to drug development status with large pharmaceutical backing, then watch out. Any inflow of money from the pharmaceutical sector would push PRLN back over $5 a share in a hurry. There are plenty of biotechs out there with no more potential than PRLN that trade at lofty levels. As always, it depends on the quality of the science and effectiveness of management.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News